Opening of Bids - Demolition of Rabbi Shulman Apartments Proj No 125-014 - Pitsch Companies

Home Browse Search

Appendix A6 - Training Materials/Employees PCP (Phencyclidine) PCP is not used in medicine and does not occur in nature. PCP's use as a human anesthetic was discontinued because it produced psychotic reactions, and its more prolonged use as a veterinary tranquilizing agent also has stopped. Thus, the druq now has no therapeutic role; its use is strictly illegal. It is commonly sold as a creamy, granular powder (brown or white) and is often packaged in one -inch -square aluminum foil or folded paper packets. Occasionally, PCP is sold in capsule, tablet or liquid form. It is sometime smoked in marijuana, tobacco, or other leafy materials. Since monkeys repeatedly self-administer PCP intravenously, resulting in gross intoxication, the drug is said to reinforce self -administration behavior in animals. Some human beings also repeatedly and chronically self-administer PCP. This behavioral reinforcement is striking, considering the drug's pronounced adverse effects. The psychosis which sometimes develops with intoxication may be long-lasting, and there are suggestions of personality and cognitive changes persisting for months after chronic use. Its toxicity has given it a bad reputation even among drug users, who often are not very discriminating in these matters. It remains a popular drug of abuse in certain cities, notably Washington, DC, Los Angeles, CA, and Baltimore, MD.; but occurs sporadically elsewhere. Si ns and Symptoms: Evidence of Presence: foil or paper packets; stamps (off which PCP is licked); injection paraphernalia (needles, syringes, and tourniquets); leafy herbs (for smoking). Physical Symptoms: dilated or floating pupils; blurred vision; nystagmus (jerky eye movement); drooling; muscle rigidity; profuse sweating; decreased sensitivity to pain; dizziness; drowsiness; impaired coordination (e.g., drunken -like walk, staggering); severe disorientation; rapid heartbeat. Behavioral Symptoms anxiety; paniclfearlterror; aggressive/violent behavior; distorted perception; severe confusion and agitation; disorganization; mood swings; poor perception of time and distance; poor judgment; auditory hallucinations. Personal Health, Safety, and the Work Environment: General Health Effects: There are 4 phases to PCP abuse. ■ Phase 1/Acute toxicity: can last up to three days and can include combativeness, catatonia, convulsions, and coma. Distortions of size, shape, and distance perceptions are common. ■ Phase 21Toxic psychosis: while this phase does not always follow the first, users may experience visual and auditory delusions, paranoia, and agitation. ■ Phase 3lDrug-induced schizophrenia: may last a month or longer. • Phase 4/Drug-induced depression: suicidal tendencies and mental dysfunction can last for months. Safety and the Work Environment: Regular use can cause the following effects: ■ Irreversible memory loss ■ Personality changes ■ Thought disorders • Hallucinations ■ Extreme mental/anesthetic effects create high potential for accidents and for overdose emergencies. • Because the effects are aggravated by other depressant drugs such as alcohol, overdose potential is high. • PCP -induced hallucinations may be misdiagnosed as LSD -induced. The standard treatment for LSD -induced hallucinations is Thorazine, which when administered with PCP can be fatal. • Distortions in perception, and potential visual and auditory delusions make performance unpredictable and dangerous in safety -sensitive positions. • PCP use can cause drowsiness, convulsions, paranoia, agitation, or coma, all obviously dangerous in any safety -sensitive position. Overdose Effects: ■ Longer, more intense "trip" episodes ■ Psychosis ■ Coma ■ Death Withdrawal Syndrome: • None reported 2020 Drug Screens Plus. All Rights Reserved. (27) FMCSA 20200101 266